Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This prospective, randomized, controlled trial will compare the incidence of nosocomial infections (composite of primary bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections) that occur in intensive care unit (ICU) patients bathed with 2% chlorhexidine solution versus patients who receive standard bathing (soap and water or non-medicated cloths).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Joshua Swan
• Collaborators: Texas Southern University; The Methodist Hospital Research Institute; The Methodist Hospital System
• Treatments: Chlorhexidine; Chlorhexidine gluconate

Criteria

Inclusion Criteria:

• Admission to the surgical intensive care unit at The Methodist Hospital (Houston, TX)

• Anticipated surgical intensive care unit length of stay of 48 hours or more

Exclusion Criteria:

• Pregnancy

• Age less than 18 years old

• Braden score of less than 9 upon admission to the surgical intensive care unit

• Known allergy to chlorhexidine gluconate

• Active skin irritation upon admission to the surgical intensive care unit